Condition

Lupus Nephritis clinical trials and research

• 43Clinical trials
• 47NIH research projects
• 35Countries

Newest Lupus Nephritis clinical trials

All recruiting trials (43)

• TranspoCART19 CAR-T therapy in adults with refractory lupus nephritis

  This trial tests whether a patient’s own CD19 CAR-T cells can be safely given and potentially help adults with lupus nephritis that isn’t responding to standard treatments.

  Recruiting Phase 1/2 Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Badalona, Barcelona and 7 other locations · NCT07799116

• Triple therapy with voclosporin, MMF and prednisolone in lupus nephritis

  This trial tests whether adding voclosporin to standard lupus nephritis treatment (MMF and prednisolone) early on improves kidney inflammation compared to standard therapy alone.

  Recruiting Phase 4 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT07760480

• Biomarker tests in adults with lupus to see how kidney disease changes over time

  Researchers will follow adults with lupus to see if blood and urine biomarkers can predict kidney involvement, flares, and treatment responses during routine care.

  Recruiting Oslo University Hospital · Oslo, Oslo · NCT07666711

• LUPKYNIS in combination with belimumab, obinutuzumab, or anifrolumab for lupus nephritis

  This trial tests whether adding LUPKYNIS to other biologics (belimumab, obinutuzumab, or anifrolumab) plus a mycophenolic acid analog and a steroid can rapidly improve kidney health in adults with biopsy-proven lupus nephritis.

  Recruiting at 27 sites Phase 4 Aurinia Pharmaceuticals Inc. · La Mesa, California and 26 other locations · NCT07611214

• Mosunetuzumab for people with systemic lupus erythematosus

  This study tests mosunetuzumab in people with systemic lupus erythematosus, with or without active lupus nephritis.

  Recruiting at 24 sites Phase 2 Hoffmann-La Roche · CABA, Buenos Aires and 23 other locations · NCT07598396

• FT819 in Lupus Nephritis: a targeted cell therapy trial for moderate-to-severe LN

  This trial tests whether FT819, a donor-derived CAR T cell therapy, can help people with difficult-to-treat lupus nephritis who have not responded to other medicines.

  Recruiting at 12 sites Phase 2 Fate Therapeutics · Beverly Hills, California and 11 other locations · NCT07570862

• Biomarker-guided CAR-T target selection for refractory lupus

  This trial tests whether using a lab-based immune profile to pick CD19- or BCMA-targeted CAR-T can help adults with refractory lupus, including lupus nephritis, who have not responded to standard treatments.

  Recruiting Phase 1/2 Beijing Biotech · Shenzhen, Guangdong · NCT07523542

• Combining belimumab and voclosporin for proliferative lupus kidney disease

  This trial will test whether giving belimumab and voclosporin together with background mycophenolate helps people with proliferative lupus nephritis reach complete kidney remission and lets doctors stop mycophenolate sooner.

  Recruiting at 7 sites Phase 4 NephroNet, Inc. · Glendale, Arizona and 6 other locations · NCT07225387

• UB-VV410 for adults with active, treatment-refractory systemic lupus and lupus nephritis

  This trial will test whether UB-VV410 is safe and how it acts in adults with active, treatment-refractory systemic lupus erythematosus, including those with lupus nephritis.

  Recruiting Phase 1 Nanjing IASO Biotechnology Co., Ltd. · Nanjing · NCT07109986

• Survey of LUPKYNIS (voclosporin) use in lupus nephritis

  This survey will collect safety and effectiveness information about LUPKYNIS (voclosporin) in people who are newly starting treatment for lupus nephritis.

  Recruiting Otsuka Pharmaceutical Co., Ltd. · Osaka · NCT07053891

• Obe-cel for severe, treatment-resistant lupus nephritis

  This study will test whether a single infusion of obe-cel, a CD19 CAR‑T cell therapy, can put adolescents and adults (ages 12–65) with severe, treatment‑resistant lupus nephritis into remission.

  Recruiting at 16 sites Phase 2 Autolus Limited · New York, New York and 15 other locations · NCT07053800

• Evaluating CTX112 for treating refractory autoimmune diseases in adults

  This study is testing a new CAR T cell treatment called CTX112 to see if it can help adults with tough autoimmune diseases like lupus and scleroderma feel better.

  Recruiting at 16 sites Phase 1 CRISPR Therapeutics · La Jolla, California and 16 other locations · NCT06925542

• CAR T cell therapy for children with lupus nephritis

  This study is testing a new CAR T cell therapy to see if it can help children with lupus nephritis who haven't responded to other treatments.

  Recruiting Phase 3 Guangzhou Women and Children's Medical Center · Guangzhou, Guangdong · NCT06904729

• CAR-T Cell Therapy for Lupus Nephritis

  This study is testing a new CAR-T cell therapy to see if it can help people with tough-to-treat lupus nephritis feel better.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06785519

• Long-term follow-up of ianalumab with or without stopping treatment for people with lupus nephritis

  This 2-year extension will test whether continuing or stopping ianalumab keeps kidney disease under control and is safe for people with lupus nephritis who completed the core study.

  Recruiting at 50 sites Phase 3 Novartis · Orchard Park, New York and 52 other locations · NCT06711887

• Zamtocabtagene Autologous CAR-T for Autoimmune Diseases

  This early-phase study tests whether a patient’s own CAR-T cells (zamto-cel) can be safely given after standard therapy to people with lupus or systemic sclerosis.

  Recruiting Phase 1 Miltenyi Biomedicine GmbH · Milwaukee, Wisconsin · NCT06708845

• Using CAR NK cells to treat adults with lupus nephritis

  This study is testing a new CAR NK cell therapy to see if it can safely help adults with active lupus nephritis feel better.

  Recruiting at 18 sites Phase 1/2 Nkarta, Inc. · Little Rock, Arkansas and 18 other locations · NCT06557265

• Assessing the effectiveness of belimumab for lupus nephritis treatment

  This study is testing how well belimumab works for adults with active lupus nephritis to see if it helps protect their kidney function over time.

  Recruiting at 7 sites GlaxoSmithKline · Baltimore, Maryland and 6 other locations · NCT06527872

• Evaluating PRG-1801 for treating difficult cases of Lupus Nephritis and IgG4-Related Disease

  This study is testing a new treatment called PRG-1801 to see if it can help adults with tough cases of Lupus Nephritis and IgG4-Related Disease feel better.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06497387

• Evaluating PRG-2311 for treating difficult cases of Lupus Nephritis and IgG4-Related Disease

  This study is testing a new treatment called PRG-2311 to see if it can help people with tough cases of Lupus Nephritis and IgG4-Related Disease improve their kidney function and overall health.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06497361

• Combination treatment for autoimmune disorders using specialized cells and chemotherapy

  This study is testing a new combination of specialized cells and chemotherapy to see if it can help people with autoimmune disorders like systemic sclerosis and lupus feel better.

  Recruiting at 2 sites Phase 1/2 M.D. Anderson Cancer Center · Houston, Texas and 1 other locations · NCT06434363

• Evaluating QLG1074 for treating active lupus nephritis

  This study is testing if a new treatment called QL1074 can help people with active lupus nephritis improve their kidney function when used alongside standard medications.

  Recruiting at 9 sites Phase 3 Qilu Pharmaceutical Co., Ltd. · Bengbu, Anhui and 9 other locations · NCT06406205

• Evaluating FT819 for autoimmune diseases

  This study is testing a new treatment called FT819 to see if it can safely help people with moderate to severe autoimmune diseases feel better.

  Recruiting at 21 sites Phase 1 Fate Therapeutics · Beverly Hills, California and 20 other locations · NCT06308978

• FKC288 treatment for autoimmune kidney diseases

  This study is testing a new treatment called FKC288 to see if it can help people with tough autoimmune kidney diseases like lupus nephritis and ANCA-associated vasculitis.

  Recruiting Phase 1 Nanjing University School of Medicine · Nanjing, Jiangsu · NCT06285279

• CAR-T cell therapy for treating severe autoimmune diseases

  This study is testing a new CAR-T cell therapy to see if it can help people with severe autoimmune diseases like lupus nephritis and vasculitis who haven't found relief with other treatments.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06277427

• Wellness and Coaching Support for Lupus Nephritis in Women of Color

  This study tests whether culturally matched coaching delivered through a mobile app can help women of color with lupus or lupus nephritis improve self-management.

  Recruiting Morehouse School of Medicine · Atlanta, Georgia · NCT06217107

• Identifying biomarkers for lupus nephritis treatment response

  This study is trying to find specific markers in blood and urine that can help predict how well people with lupus nephritis will respond to certain treatments.

  Recruiting Chinese SLE Treatment And Research Group · Beijing · NCT06167174

• Using SGLT2 inhibitors to treat lupus nephritis in patients with chronic kidney disease

  This study is testing if the medication dapagliflozin can improve kidney function in people with lupus nephritis and chronic kidney disease who are already receiving standard treatment.

  Recruiting Phase 2 The University of Hong Kong · Hong Kong · NCT06155604

• Evaluating CABA-201 for treating active systemic lupus erythematosus

  This study is testing a new cell therapy called CABA-201 to see if it can help people with active lupus and kidney issues feel better and protect their organs.

  Recruiting at 20 sites Phase 1/2 Cabaletta Bio · Orange, California and 22 other locations · NCT06121297

• Cell injection therapy for active lupus nephritis

  This study is testing a new cell injection therapy to see if it can help people with active lupus nephritis feel better while they continue their usual medications.

  Recruiting Phase 2 Jiangsu Renocell Biotech Company · Nanjing, Jiangsu · NCT06058078

• Registry and biorepository for lupus patients

  This study is gathering information and samples from over 3,500 people with lupus to help researchers learn more about the condition and improve treatments.

  Recruiting at 22 sites Lupus Research Alliance · Birmingham, Alabama and 24 other locations · NCT05934149

• Treatment of Lupus Nephritis in Children and Young Adults

  This study is testing two different ways of giving a medication to see which one works better for children and young adults with lupus nephritis.

  Recruiting at 19 sites Phase 2 Children's Hospital Medical Center, Cincinnati · San Francisco, California and 18 other locations · NCT05538208

• Understanding genetic signatures in lupus nephritis patients

  This study is trying to understand how certain genetic markers in people with lupus nephritis can help explain their disease and how their immune system is responding.

  Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Brussels · NCT05443516

• Reducing glucocorticoid use in patients with lupus nephritis

  This study is testing two different treatment plans for people with lupus nephritis to see which one helps reduce the use of steroids while still effectively managing their condition.

  Recruiting Phase 4 Institutul Clinic Fundeni · Bucharest · NCT05207358

• VIB4920 treatment for active lupus nephritis

  This study is testing if a new treatment called VIB4920, given with other medications, can help people with active lupus nephritis feel better and improve their kidney function.

  Recruiting at 15 sites Phase 2 National Institute of Allergy and Infectious Diseases (NIAID) · La Jolla, California and 16 other locations · NCT05201469

• Evaluating Obinutuzumab for Lupus Nephritis in Adolescents

  This study is testing if a medication called obinutuzumab can help teenagers with lupus nephritis feel better and improve their kidney health.

  Recruiting at 33 sites Phase 2 Hoffmann-La Roche · Loma Linda, California and 43 other locations · NCT05039619

• Comparing treatments for lupus nephritis without added oral steroids

  This study is testing whether a treatment for lupus nephritis using obinutuzumab and mycophenolate mofetil without steroids can work just as well as a treatment that includes steroids.

  Recruiting Phase 3 Assistance Publique - Hôpitaux de Paris · Paris · NCT04702256

• Repeat kidney biopsy for lupus nephritis patients

  This study tests whether doing repeat kidney biopsies can help doctors make better treatment decisions for patients with lupus nephritis by looking at tissue changes even when symptoms seem normal.

  Recruiting Karolinska Institutet · Stockholm · NCT04449991

• A network for analyzing kidney biopsy data in glomerular diseases

  This study is trying to build a detailed database of kidney biopsy samples and health information from patients with glomerular diseases to help researchers better understand these conditions and improve treatments.

  Recruiting at 6 sites Seoul National University Hospital · Chuncheon and 5 other locations · NCT03929887

• Using stem cells to treat lupus nephritis

  This study is testing if bone marrow stem cells can help adults with lupus nephritis who haven't responded well to regular treatments feel better.

  Recruiting Phase 2 Red de Terapia Celular · Valladolid, Valladolid · NCT03673748

• Creating a database for patients with lupus nephritis in China

  This study is creating a database of patients with lupus nephritis in China to gather important health information that can help improve care and understanding of the condition over time.

  Recruiting Sun Yat-sen University · Guangzhou, Guangdong · NCT03001973

• Effects of Mycophenolate Mofetil and Cyclophosphamide on Lymphocyte Subsets in Lupus Nephritis

  This study is testing whether two different medications, mycophenolate mofetil and cyclophosphamide, can change certain immune cells in people with lupus nephritis to see which treatment works better.

  Recruiting The University of Hong Kong · Hong Kong · NCT02954939

• Data repository for kidney diseases and related conditions

  This study is collecting health information and samples from people with different kidney diseases to see how various factors affect their condition and treatment.

  Recruiting The Rogosin Institute · New York, New York · NCT01802034

NIH-funded research (newest 40 of 47)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Glycoprotein urine markers that signal lupus nephritis treatment response

  A novel test uses urine glycoprotein patterns to show how well lupus nephritis is responding to standard treatment.

  NIH research Medical University of South Carolina · Charleston, United States · NIH-11550186

• PTPRS and lupus nephritis: a new target to reduce kidney damage in lupus

  Aims to understand how PTPRS contributes to kidney inflammation and scarring in lupus nephritis and explore targeting it to help patients.

  NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11465789

• Sodium’s effect on kidney B cells in lupus kidney disease

  This grant explores how high sodium in the kidneys affects B cells in lupus nephritis and whether blocking a key cellular pump could reduce kidney damage.

  NIH research Yale University · New Haven, United States · NIH-11385489

• Oral CD11b Activator for Lupus Nephritis

  A new oral CD11b activating drug is being explored to help people with lupus nephritis by targeting immune pathways that cause kidney inflammation.

  NIH research University of Texas Med Br Galveston · Galveston, United States · NIH-11380829

• Objective classification of lupus nephritis using computer vision

  A new computer vision tool uses deep learning to classify lupus nephritis from kidney tissue images to help doctors predict outcomes for patients with lupus.

  NIH research University of Houston · Houston, United States · NIH-11377551

• AI-powered look at lupus nephritis in humans and mice

  Researchers will use artificial intelligence to compare kidney tissue from people with lupus nephritis to tissue from mouse models, aiming to understand why treatments work differently in humans.

  NIH research University of Chicago · Chicago, United States · NIH-11369129

• miR-21 and B cells in lupus: how a tiny molecule can drive autoimmunity

  Aims to understand how a microRNA called miR-21 influences B cells and kidney inflammation in lupus, with the goal of finding targeted therapies for people with SLE.

  NIH research Thomas Jefferson University · Philadelphia, United States · NIH-11367446

• Lupus Nephritis: How T cells cause kidney damage and how to stop them

  A study at Yale will follow people and tissue samples to understand how certain immune cells cause kidney damage in lupus and explore ways to target them.

  NIH research Yale University · New Haven, United States · NIH-11366056

• Autoimmunity-Linked B Cells in Lupus Kidney Disease

  A study to understand how a special immune cell subset called autoimmunity-associated B cells behave in lupus nephritis and how they may become antibody-making cells.

  NIH research University of Rochester · Rochester, United States · NIH-11335628

• Pharmacokinetically guided dosing of mycophenolate mofetil for pediatric lupus nephritis

  A kid-focused trial will test whether adjusting mycophenolate mofetil dosing by pharmacokinetics improves kidney remission for children with proliferative lupus nephritis.

  NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11333765

• Nanoparticles that target the kidney to treat lupus nephritis

  This project delivers prednisolone directly to the kidney glomeruli using targeted nanoparticles to help people with lupus nephritis while reducing systemic side effects.

  NIH research University of South Florida · Tampa, United States · NIH-11332953

• Finding lupus kidney inflammation early with a urine protein test

  Testing whether a urine protein test can detect early kidney inflammation in people with lupus before permanent damage occurs.

  NIH research Johns Hopkins University · Baltimore, United States · NIH-11327251

• New approaches to lupus-related kidney inflammation

  This project looks at how immune cells and kidney cells interact to cause lupus-related kidney damage and explores targeted treatments for people with lupus nephritis.

  NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11324178

• Looking closely at kidneys affected by lupus nephritis to learn what goes wrong

  This work uses high-detail tissue mapping of kidney biopsies from people with lupus nephritis, including children, to find the specific cells and genes driving kidney damage.

  NIH research Seattle Children's Hospital · Seattle, United States · NIH-11309987

• Digital analysis of kidney biopsy images for lupus nephritis

  Using computerized analysis of digitized kidney biopsy images to find features that predict how lupus nephritis will behave in adults, especially people of African ancestry.

  NIH research University of Michigan at Ann Arbor · Ann Arbor, United States · NIH-11299563

• Blocking iron-driven cell death in kidney tubules for lupus nephritis

  Researchers aim to stop a type of iron-driven cell death in kidney tubules to help protect kidneys and lower the chance of kidney failure in people with lupus nephritis.

  NIH research University of Florida · Gainesville, United States · NIH-11295394

• Immune cells in lupus-related kidney inflammation

  This project looks at different immune cells called myeloid cells in kidneys to learn how they cause or repair damage in people with lupus nephritis.

  NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11247065

• More accurate lupus kidney diagnosis using new imaging biomarkers

  This project uses two advanced imaging methods plus AI to help doctors read kidney biopsies more accurately for people with lupus nephritis.

  NIH research University of Houston · Houston, United States · NIH-11237166

• Using AI to better understand lupus kidney disease

  This project uses advanced computer tools to compare kidney tissue from people and mice with lupus, hoping to find better ways to predict and treat the disease.

  NIH research University of Chicago · Chicago, United States · NIH-11170635

• Understanding how a tiny molecule affects lupus and kidney problems

  This research explores how a small molecule called miR-21 contributes to lupus and its effects on the kidneys.

  NIH research Thomas Jefferson University · Philadelphia, United States · NIH-11139640

• Antibody sugar patterns in lupus kidney disease

  Researchers are seeing whether unusual sugar decorations on antibodies lead to kidney damage in people with lupus.

  NIH research Tulane University of Louisiana · New Orleans, United States · NIH-11138781

• Oral pill that boosts CD11b to treat lupus-related kidney inflammation

  An oral pill called ONTEGIMOD aims to activate a protein (CD11b) to reduce kidney inflammation in people with lupus nephritis.

  NIH research University of Texas Med Br Galveston · Galveston, United States · NIH-11136537

• Treating blood-vessel damage in lupus-related kidney disease

  Researchers are trying sepiapterin, a compound that may improve blood-vessel cell health and reduce kidney inflammation for people with lupus nephritis.

  NIH research Ralph H Johnson VA Medical Center · Charleston, United States · NIH-11132601

• Improving how we identify lupus kidney disease

  This project uses computer technology to help doctors better identify and classify kidney disease in people with lupus.

  NIH research University of Houston · Houston, United States · NIH-11125957

• Understanding ABIN1 in Lupus Kidney Disease

  This project looks at how a protein called ABIN1 contributes to lupus kidney disease, especially in African American patients, to find better ways to help them.

  NIH research University of Louisville · Louisville, United States · NIH-11125954

• Targeted treatment for kidney damage in lupus using nanoparticles

  This study is testing a new way to treat lupus nephritis by using tiny particles to deliver medicine directly to the damaged parts of your kidneys, aiming to make treatment safer and more effective for people with this condition.

  NIH research University of South Florida · Tampa, United States · NIH-11115578

• Investigating B cells involved in lupus nephritis

  This study is looking at special immune cells that can cause kidney problems in people with lupus, and it aims to learn how these cells work and what makes them harmful, so we can find better ways to treat lupus nephritis.

  NIH research University of Rochester · Rochester, United States · NIH-11091641

• Investigating how changes in IgG glycosylation affect kidney injury in lupus nephritis

  This study is looking at how certain changes in antibodies might affect kidney health in people with lupus nephritis, hoping to find new ways to prevent kidney damage for those dealing with this condition.

  NIH research Tulane University of Louisiana · New Orleans, United States · NIH-11080116

• Investigating a new dosing method for treating pediatric lupus nephritis

  This study is looking at how to make treatment better for kids with lupus kidney disease by comparing two ways of giving a medication called mycophenolate mofetil (MMF) to see which one helps their kidneys work better.

  NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11077820

• Understanding lupus nephritis at the cellular level using advanced techniques

  This study is looking at kidney tissue from kids with lupus nephritis to better understand how the disease affects them, with the hope of finding new treatments that work better for their specific needs.

  NIH research Seattle Children's Hospital · Seattle, United States · NIH-11060920

• Using digital technology to analyze kidney biopsies in lupus nephritis patients

  This study is looking to make it easier and more accurate to diagnose and manage kidney problems caused by lupus, especially for patients of African ancestry, by using advanced technology to better understand kidney biopsies and help doctors catch issues early so they can provide better care.

  NIH research University of Michigan at Ann Arbor · Ann Arbor, United States · NIH-11049028

• Understanding and treating lupus nephritis

  This study is looking into what causes kidney problems in people with lupus and how we can better treat it, especially for kids and those from minority backgrounds, by examining urine samples to find out how the immune system affects the kidneys.

  NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11046578

• Improving kidney health in lupus nephritis by targeting cell death mechanisms

  This study is looking at how too much iron in kidney cells can cause harmful cell death in people with lupus nephritis, and it aims to find new ways to help improve kidney health for those affected by this condition.

  NIH research University of Florida · Gainesville, United States · NIH-11017808

• Improving lupus nephritis diagnosis using advanced imaging techniques

  This study is looking to improve how doctors diagnose lupus nephritis by combining regular tissue examination with new imaging technology, making it easier to spot important details in kidney tissue that can help with accurate diagnosis.

  NIH research University of Houston · Houston, United States · NIH-11005060

• Using urine tests to detect lupus nephritis early

  This study is looking at urine samples from people with lupus to find early signs that could predict kidney problems before they happen, so that doctors can help prevent serious damage and offer safer treatments.

  NIH research Johns Hopkins University · Baltimore, United States · NIH-11001208

• Understanding myeloid cells in lupus nephritis

  This study is looking at how certain immune cells in the body, called macrophages, affect kidney problems in people with lupus, and it hopes to find new ways to treat this condition by understanding these cells better.

  NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11000308

• Using AI to understand lupus nephritis progression in humans and mice

  This study is exploring how artificial intelligence can help us understand lupus nephritis better by comparing tissue samples from people and mice, with the goal of finding new ways to predict and improve treatments for this serious kidney condition.

  NIH research University of Chicago · Chicago, United States · NIH-10981178

• Preventing heart disease in patients with lupus nephritis

  This study is looking to find better ways to prevent heart disease in Black patients with lupus nephritis, especially focusing on who might benefit most from certain treatments and how to make those treatments safer, particularly for young women who are pregnant.

  NIH research University of Wisconsin-Madison · Madison, United States · NIH-10949235

• Investigating how sodium affects kidney B cells in lupus nephritis

  This study is looking at how high sodium levels in the kidneys affect certain immune cells that can harm the kidneys in people with lupus nephritis, with the hope of finding new ways to help treat this condition.

  NIH research Yale University · New Haven, United States · NIH-10907612

• Investigating antibodies linked to modified nucleosomes in lupus nephritis

  This study is looking at how certain antibodies in people with lupus nephritis can help doctors better understand the disease and improve diagnosis, using a new test that tracks these antibodies as the condition changes.

  NIH research University of Houston · Houston, United States · NIH-10906078

Related topics

Quick answers

How many Lupus Nephritis clinical trials are recruiting right now?

43, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 35 countries. The most sites are in United States (18 trials), China (13 trials), Spain (6 trials), France (5 trials), Brazil (4 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 9, Phase 1: 5, Phase 1/2: 5, Phase 4: 4. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →